|Videos|January 12, 2017
What's Exciting in the Field of MPNs?
Author(s)Ross L. Levine, M.D.
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Advertisement
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Levine and his team are turning their focus to the JAK2 gene to build on recent successes in the field and hopefully develop some novel approaches. They are also investigating other possible genetic mutations that can be blocked.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
2
What Breast Cancer Survivors Should Know About Weight Loss and Long-Term Health
3
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
4
Etentamig Improves Responses and Progression-Free Survival in Relapsed Multiple Myeloma
5